During our discussion we touched on how cancer drug development differs from other areas, the complex interplay of diagnostics and personalised medicine, the impact pharma has made on the disease ...

In our oncology focus month, Ryan McGuire takes a look at the impact of clinical development on cancer drug prices and the factors involved in the current improved success rate for cancer treatments.

Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Follicular Thyroid Cancer.

NVL-330 is under development for the treatment of non-small cell lung cancer. The drug candidate act by targeting HER2. It is administered by oral route in the form of tablet.

Merck MRK decided to discontinue two clinical development programs, namely KeyVibe and KEYFORM, which are evaluating its investigational cancer drugs vibostolimab and favezelimab, respectively.

Huch’s pancreatic organoids are now a promising avenue for disease modeling and generating precision medicines to treat ...

Such mutations lead to up to a third of all cancer. Shokat’s breakthrough led to the development of drugs that latched onto cancerous KRAS. But the drugs could only shrink tumors for a few ...

Dr. Artem Cherkasov remarked, “With these newly synthesized drug candidates identified and now advancing into testing, Rakovina Therapeutics is delivering on its promise of innovation. This ...

Cancer is a deadly disease taking the lives of thousands of people worldwide, and researchers are constantly looking for ...

Designation will ease the gene-based breakthrough’s transition from laboratory to clinic with tax breaks and other investment ...

Researchers are developing the world’s first topical cream to prevent and treat skin cancer, especially for organ transplant ...

Roche acquires ADC rights from Innovent for lung cancer treatment in $1 billion deal Roche strengthens its global foothold in ...